Literature DB >> 12112684

Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity.

Glen B Legge1, Garrett M Morris, Michel F Sanner, Yoshikazu Takada, Arthur J Olson, Flavio Grynszpan.   

Abstract

The interaction of the alphaLbeta2 integrin with its cellular ligand the intercellular adhesion molecule-1 (ICAM-1) is critical for the tight binding interaction between most leukocytes and the vascular endothelium before transendothelial migration to the sites of inflammation. In this article we have modeled the alphaL subunit I-domain in its active form, which was computationally docked with the D1 domain of the ICAM-1 to probe potential protein-protein interactions. The experimentally observed key interaction between the carboxylate of Glu 34 in the ICAM-1 D1 domain and the metal ion-dependent adhesion site (MIDAS) in the open alphaL I-domain was consistently reproduced by our calculations. The calculations reveal the nature of the alphaLbeta2/ICAM-1 interaction and suggest an explanation for the increased ligand-binding affinity in the "open" versus the "closed" conformation of the alphaL I-domain. A mechanism for substrate selectivity among alphaL, alphaM, and alpha2 I-domains is suggested whereby the orientation of the loops within the I-domain is critical in mediating the interaction of the Glu 34 carboxylate of ICAM-1 D1 with the MIDAS. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112684     DOI: 10.1002/prot.10134

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  7 in total

1.  Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas.

Authors:  Richard D Carpenter; Arutselvan Natarajan; Edmond Y Lau; Mirela Andrei; Danielle M Solano; Felice C Lightstone; Sally J Denardo; Kit S Lam; Mark J Kurth
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.

Authors:  Roberto Carreño; Wells S Brown; Dan Li; Jessica A Hernandez; Yang Wang; Tae Kon Kim; John W Craft; Krishna V Komanduri; Laszlo G Radvanyi; Patrick Hwu; Jeffrey J Molldrem; Glen B Legge; Bradley W McIntyre; Qing Ma
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

3.  LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells.

Authors:  Yang Wang; Dan Li; Roza Nurieva; Justin Yang; Mehmet Sen; Roberto Carreño; Sijie Lu; Bradley W McIntyre; Jeffrey J Molldrem; Glen B Legge; Qing Ma
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

4.  The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle.

Authors:  Wenwu Xiao; Yan Wang; Edmond Y Lau; Juntao Luo; Nianhuan Yao; Changying Shi; Leah Meza; Harry Tseng; Yoshiko Maeda; Pappanaicken Kumaresan; Ruiwu Liu; Felice C Lightstone; Yoshikazu Takada; Kit S Lam
Journal:  Mol Cancer Ther       Date:  2010-09-21       Impact factor: 6.261

5.  Automated docking with protein flexibility in the design of femtomolar "click chemistry" inhibitors of acetylcholinesterase.

Authors:  Garrett M Morris; Luke G Green; Zoran Radić; Palmer Taylor; K Barry Sharpless; Arthur J Olson; Flavio Grynszpan
Journal:  J Chem Inf Model       Date:  2013-03-29       Impact factor: 4.956

6.  Synthesis and characterization of a novel inhibitor of C-reactive protein-mediated proinflammatory effects.

Authors:  Pappanaicken R Kumaresan; Sridevi Devaraj; Wenzhe Huang; Edmond Y Lau; Ruiwu Liu; Kit S Lam; Ishwarlal Jialal
Journal:  Metab Syndr Relat Disord       Date:  2013-02-27       Impact factor: 1.894

7.  Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

Authors:  Yang Wang; Dan Li; Dan Jones; Roland Bassett; George E Sale; Jahan Khalili; Krishna V Komanduri; Daniel R Couriel; Richard E Champlin; Jeffrey J Molldrem; Qing Ma
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.